OBJECTIVES: The objective of this study is to describe the quality of life (QoL) in cancer patients with solid tumors and at different chemotherapy (CT) cycles. METHODS: A total of 200 cancer patients were included. With some modification, the European Organization for Research and Treatment of Cancer QoL Questionnaire (EORTC QLQ-C30) was used to measure QoL in the student patients. RESULTS: There was no correlation between the QoL and variables such as age, sex, marital status, duration of disease, economic conditions, and occupational function. Furthermore, no correlation was found between QoL and the patients' educational level (literate or illiterate). Nevertheless, a significant difference was found between the level of QoL in patients with ≤ 2 CT cycles and/or with 3-5 cycles (p< 0.001). CONCLUSION: This study suggests that encouraging cancer patients to complete a CT course plays an important role in the treatment outcome and the QoL in cancer patients undergoing CT.
OBJECTIVES: The objective of this study is to describe the quality of life (QoL) in cancerpatients with solid tumors and at different chemotherapy (CT) cycles. METHODS: A total of 200 cancerpatients were included. With some modification, the European Organization for Research and Treatment of Cancer QoL Questionnaire (EORTC QLQ-C30) was used to measure QoL in the student patients. RESULTS: There was no correlation between the QoL and variables such as age, sex, marital status, duration of disease, economic conditions, and occupational function. Furthermore, no correlation was found between QoL and the patients' educational level (literate or illiterate). Nevertheless, a significant difference was found between the level of QoL in patients with ≤ 2 CT cycles and/or with 3-5 cycles (p< 0.001). CONCLUSION: This study suggests that encouraging cancerpatients to complete a CT course plays an important role in the treatment outcome and the QoL in cancerpatients undergoing CT.
Authors: C Hürny; J Bernhard; A S Coates; M Castiglione-Gertsch; H F Peterson; R D Gelber; J F Forbes; C M Rudenstam; E Simoncini; D Crivellari; A Goldhirsch; H J Senn Journal: Lancet Date: 1996-05-11 Impact factor: 79.321
Authors: Patricia A Ganz; Katherine A Desmond; Beth Leedham; Julia H Rowland; Beth E Meyerowitz; Thomas R Belin Journal: J Natl Cancer Inst Date: 2002-01-02 Impact factor: 13.506
Authors: Galina Velikova; Noha Awad; Rebecca Coles-Gale; E Penny Wright; Julia M Brown; Peter J Selby Journal: Psychooncology Date: 2008-07 Impact factor: 3.894
Authors: Paolo Boscolo-Rizzo; Francesca Maronato; Carlo Marchiori; Alessandro Gava; Maria Cristina Da Mosto Journal: Laryngoscope Date: 2008-02 Impact factor: 3.325
Authors: Barry V Fortner; Edward J Stepanski; Stephanie C Wang; Sarah Kasprowicz; H Heith Durrence Journal: J Pain Symptom Manage Date: 2002-11 Impact factor: 3.612
Authors: Elena Álvaro Sanz; Jimena Abilés; Margarita Garrido Siles; Elísabeth Pérez Ruíz; Julia Alcaide García; Antonio Rueda Domínguez Journal: Support Care Cancer Date: 2020-05-18 Impact factor: 3.603
Authors: Ilufredo Y Tantoy; Bruce A Cooper; Anand Dhruva; Janine Cataldo; Steven M Paul; Yvette P Conley; Marilyn Hammer; Kord M Kober; Jon D Levine; Christine Miaskowski Journal: Qual Life Res Date: 2018-04-21 Impact factor: 4.147